Beneficient (NASDAQ:BENF – Get Free Report)’s share price was down 3.7% during mid-day trading on Tuesday . The company traded as low as $2.11 and last traded at $2.11. Approximately 5,056 shares changed hands during mid-day trading, a decline of 98% from the average daily volume of 292,356 shares. The stock had previously closed at $2.19.
Beneficient Stock Up 28.2 %
The stock has a 50 day moving average price of $2.43.
Hedge Funds Weigh In On Beneficient
Several institutional investors and hedge funds have recently added to or reduced their stakes in BENF. Hatteras Investment Partners LP acquired a new position in shares of Beneficient during the second quarter worth $148,288,000. Rivernorth Capital Management LLC bought a new stake in Beneficient during the 2nd quarter worth $8,022,000. State Street Corp bought a new stake in Beneficient during the 2nd quarter worth $83,000. Tower Research Capital LLC TRC bought a new stake in Beneficient during the 2nd quarter worth $55,000. Finally, Citadel Advisors LLC bought a new stake in Beneficient during the 2nd quarter worth $35,000.
Beneficient Company Profile
Beneficient, a technology-enabled financial service company, provides liquidity solutions and related trust, custody and administrative services to participants in the alternative asset industry. The company operates through Ben Liquidity, Ben Custody, and Customer ExAlt Trusts segments. It offers AltAccess platform for secure, online, and end-to-end delivery of each of the Ben business unit products and services, including upload documents, and work through tasks and complete their transactions with standardized transaction agreements.
See Also
- Five stocks we like better than Beneficient
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Why Ambarella’s 20% Decline is a Strong Signal for New Investment
- What is Forex and How Does it Work?
- Why Analysts Love These 2 Car Sales Platforms, And Avoid Dealers
- Stock Dividend Cuts Happen Are You Ready?
- A Significant Reversal is in Sight for These 5 Med Tech Companies
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.